scispace - formally typeset
J

John G.F. Cleland

Researcher at National Institutes of Health

Publications -  1276
Citations -  125527

John G.F. Cleland is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 137, co-authored 1172 publications receiving 110227 citations. Previous affiliations of John G.F. Cleland include Northwestern University & Imperial College London.

Papers
More filters
Journal ArticleDOI

The assessment of autonomic function in chronic atrial fibrillation: Description of a non-invasive technique based on circadian rhythm of atrioventricular nodal functional refractory periods

TL;DR: A simple index to assess autonomic function in patients with chronic AF is developed and whether DeltaFRP in chronic AF patients can independently predict adverse prognosis or sudden death requires further study.
Journal ArticleDOI

Chronic Obstructive Pulmonary Disease and Heart Failure: A Breathless Conspiracy.

TL;DR: The diagnostic challenges in individuals with exertional dyspnea are discussed and the prevalence, clinical relevance, and therapeutic implications of a concurrent diagnosis of COPD and HF are highlighted.
Journal Article

The renal effects of dopamine and dobutamine in stable chronic heart failure.

TL;DR: Results suggest that direct stimulation of beta-1 receptors increases urinary sodium excretion, either by a direct effect on the kidney or by altering systemic and renal haemodynamics.
Journal ArticleDOI

N-terminal brain natriuretic peptide as a screening tool for heart failure in the pacemaker population.

TL;DR: Assessment of N-terminal brain natriuretic peptide (NT-BNP) as a screening tool for heart failure in patients with a permanent pacemaker is feasible and assists in the detection of important cardiac co-morbidity, particularly in Patients with a DDD type pacemaker.
Journal ArticleDOI

Revascularization for patients with heart failure. Inconsistencies between theory and practice.

TL;DR: The theory that treatments for coronary atherosclerosis are effective or imperative for good clinical care of patients with heart failure is now in tatters having been put repeatedly to the test, and it is time to take stock and find out why the theory did not translate into practice.